ArticleCancer immunology, immunotherapy : CII2025

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.

Chaeyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.